Abbisko Cayman Limited (HKG:2256)

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2021
Innovative Medicines	546.44M	Log In	Log In
Innovative Medicines Growth	2494.53%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2021
European Union	539.16M	Log In	Log In
China	7.28M	Log In	Log In
China Growth	-65.41%	Log In	Log In